Gloria Wang | Chief Medical Officer
Shanghai Sinobioway Sunterra Biotech | China

Gloria Wang, Chief Medical Officer, Shanghai Sinobioway Sunterra Biotech

Dr. Yi (Gloria) Wang is the Chief Medical Officer of TASLY Biopharmaceutical Co., Ltd. She has more than 15 years’ experience in clinical development for novel products including small chemical compound, monoclonal antibody, recombination protein and therapeutic cellular products such as CAR-T and stem cells. She is also good at life cycle management for the pharmaceutical products. She initiated her career in medical development in Johns Hopkins University when she worked as a full-time employee  here. After entered the pharmaceutical industry she worked in Novartis and United Therapeutics Corporation et al. She led her team conducted several multiple regional clinical trials in in America, Europe and Asia-Pacific Areas and launched the products in the major markets worldwide. Dr. Wang has her M.D. from Tongji University and Ph.D. from Fudan University. She received her postdoctoral trainings from University of Massachusetts Medical School.

Appearances:



Phar-East Day 2 @ 12:00

Clinical Development of CAR-T, Stem Cells and other Cellular Therapy Products

last published: 15/Feb/19 11:45 GMT

back to speakers

 

 

DOWNLOAD PROSPECTUS

 

 

For speaking, sponsorship and exhibition opportunities contact jonathan.mottram@terrapinn.com
Tel: +65 6322 2738